Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke

NCT01584609 is registered in ClinicalTrials.gov with Penumbra Inc. as lead sponsor.

NCT NCT01584609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01584609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Lead sponsor
Penumbra Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2012
Completion date
December 31, 2017
Enrollment
198 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke from large vessel occlusion